An Ex Vivo Evaluation of Cenobamate Administered via Enteral Tubes
Author:
Funder
SK Life Science, Inc.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology
Link
https://link.springer.com/content/pdf/10.1007/s40268-020-00305-4.pdf
Reference10 articles.
1. Williams NT. Medication administration through enteral feeding tubes. Am J Health Syst Pharm. 2008;65:2347–57.
2. Jory C, et al. Going down the tubes! Impact on seizure control of antiepileptic medication given via percutaneous feeding tubes. Epilepsy Behav. 2017;74:114–8.
3. Beserra MPP, et al. Drugs via enteral feeding tubes in inpatients: dispersion analysis and safe use of dispensers. Nutr Hosp. 2017;34:257–63.
4. Reindel K, et al. In vitro evaluation of eslicarbazepine delivery via enteral feeding tubes. Hosp Pharm. 2017;52:752–60.
5. Moore KT, et al. Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube. Clin Pharmacol Drug Dev. 2014;3:321–7.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Box-Behnken response surface methodology for optimizing fluorescent detection of cenobamate using graphene quantum dots: Environmental impact assessment and pharmacokinetic applications;Microchemical Journal;2024-10
2. Relative Bioavailability of Cenobamate Administered as a Crushed Tablet, Either Orally or via Nasogastric Tube, versus an Intact Whole Tablet;The Journal of Clinical Pharmacology;2024-04-29
3. Development of a stability indicating high-performance liquid chromatography method for determination of cenobamate: study of basic degradation kinetics;BMC Chemistry;2024-04-13
4. Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature;Medicina;2023-07-28
5. Safe Use of Cenobamate in Super Refractory Status Epilepticus: A Case Series;The Neurohospitalist;2023-02-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3